BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19888530)

  • 1. The role of monocytes in thrombotic disorders. Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms.
    Shantsila E; Lip GY
    Thromb Haemost; 2009 Nov; 102(5):916-24. PubMed ID: 19888530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity.
    Lackner KJ; von Landenberg C; Barlage S; Schmitz G
    Thromb Haemost; 2000 Apr; 83(4):583-8. PubMed ID: 10780321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms.
    Pierangeli SS; Chen PP; Raschi E; Scurati S; Grossi C; Borghi MO; Palomo I; Harris EN; Meroni PL
    Semin Thromb Hemost; 2008 Apr; 34(3):236-50. PubMed ID: 18720303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelets and tissue factor.
    Lösche W
    Platelets; 2005 Sep; 16(6):313-9. PubMed ID: 16194860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Platelet polyphosphates: new mediators linking thrombosis with inflammation].
    Kerbiriou-Nabias D
    Med Sci (Paris); 2010 Apr; 26(4):343-6. PubMed ID: 20412734
    [No Abstract]   [Full Text] [Related]  

  • 6. Tissue factor expression by monocytes: regulation and pathophysiological roles.
    Osterud B
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S9-14. PubMed ID: 9819023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Material-induced tissue factor expression but not CD11b upregulation depends on the presence of platelets.
    Gorbet MB; Sefton MV
    J Biomed Mater Res A; 2003 Dec; 67(3):792-800. PubMed ID: 14613227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome.
    López-Pedrera C; Ruiz-Limón P; Aguirre MÁ; Barbarroja N; Pérez-Sánchez C; Buendía P; Rodriguez-García IC; Rodriguez-Ariza A; Collantes-Estevez E; Velasco F; Khasmahta M; Cuadrado MJ
    Ann Rheum Dis; 2011 Apr; 70(4):675-82. PubMed ID: 21173016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid syndrome patients' monocytes are "primed" to express tissue factor.
    Williams FM; Jurd K; Hughes GR; Hunt BJ
    Thromb Haemost; 1998 Nov; 80(5):864-5. PubMed ID: 9843189
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
    Morel O; Morel N; Freyssinet JM; Toti F
    Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines and hemostasis.
    Grignani G; Maiolo A
    Haematologica; 2000 Sep; 85(9):967-72. PubMed ID: 10980636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prothrombotic state in cancer: pathogenic mechanisms.
    De Cicco M
    Crit Rev Oncol Hematol; 2004 Jun; 50(3):187-96. PubMed ID: 15182825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel considerations in the pathogenesis of the antiphospholipid syndrome: involvement of the tissue factor pathway of blood coagulation.
    Adams M
    Semin Thromb Hemost; 2008 Apr; 34(3):251-5. PubMed ID: 18720304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system.
    Palmerini T; Coller BS; Cervi V; Tomasi L; Marzocchi A; Marrozzini C; Leone O; Piccioli M; Branzi A
    J Am Coll Cardiol; 2004 Oct; 44(8):1570-7. PubMed ID: 15489087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombotic state in antiphospholipid syndrome].
    Suehiro A
    Rinsho Ketsueki; 1993 May; 34(5):599-604. PubMed ID: 8315831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible involvement of chemokine-induced platelet activation in thrombophilic diathesis of antiphospholipid syndrome.
    Kubota T; Fukuya Y; Hashimoto R; Kanda T; Suzuki H; Okamura Y; Nanki T; Miyasaka N; Umezawa K
    Ann N Y Acad Sci; 2009 Sep; 1173():137-45. PubMed ID: 19758142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of the postulated mechanisms linking cancer and thrombosis.
    ten Cate H; Falanga A
    Pathophysiol Haemost Thromb; 2008; 36(3-4):122-30. PubMed ID: 19176985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers.
    Harding SA; Sarma J; Josephs DH; Cruden NL; Din JN; Twomey PJ; Fox KA; Newby DE
    Circulation; 2004 Apr; 109(16):1926-9. PubMed ID: 15078798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein promotes monocyte-platelet aggregation: an additional link to the inflammatory-thrombotic intricacy.
    Danenberg HD; Kantak N; Grad E; Swaminathan RV; Lotan C; Edelman ER
    Eur J Haematol; 2007 Mar; 78(3):246-52. PubMed ID: 17253971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clotting mechanisms and cancer: implications in thrombus formation and tumor progression.
    Falanga A; Marchetti M; Vignoli A; Balducci D
    Clin Adv Hematol Oncol; 2003 Nov; 1(11):673-8. PubMed ID: 16258469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.